Ronald Feld

18.3k total citations · 5 hit papers
247 papers, 12.9k citations indexed

About

Ronald Feld is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Ronald Feld has authored 247 papers receiving a total of 12.9k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Oncology, 102 papers in Pulmonary and Respiratory Medicine and 55 papers in Epidemiology. Recurrent topics in Ronald Feld's work include Lung Cancer Treatments and Mutations (61 papers), Lung Cancer Research Studies (57 papers) and Neutropenia and Cancer Infections (35 papers). Ronald Feld is often cited by papers focused on Lung Cancer Treatments and Mutations (61 papers), Lung Cancer Research Studies (57 papers) and Neutropenia and Cancer Infections (35 papers). Ronald Feld collaborates with scholars based in Canada, United States and New Zealand. Ronald Feld's co-authors include Frances A. Shepherd, William K. Evans, Kenneth V. I. Rolston, Natasha B. Leighl, Gerald P. Bodey, Walter T. Hughes, Jerry L. Shenep, Philip A. Pizzo, Arthur E. Brown and Lowell S. Young and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Ronald Feld

244 papers receiving 12.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer

2002 1.4k citations Ronald Feld et al. profile →
The Multinational Association for Supportive Care in Cancer Risk Index: A Multinational Scoring System for Identifying Low-Risk Febrile Neutropenic Cancer Patients

2000 768 citations Ronald Feld et al. Journal of Clinical Oncology profile →
Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.

1988 544 citations Nevin Murray, William K. Evans et al. Journal of Clinical Oncology profile →
1997 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever

1997 503 citations Ronald Feld et al. profile →
Symptomatic Toxicities Experienced During Anticancer Treatment: Agreement Between Patient and Physician Reporting in Three Randomized Trials

2015 330 citations Massimo Di Maïo, Ciro Gallo et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Ronald Feld

Since Specialization

Citations

This map shows the geographic impact of Ronald Feld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Feld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Feld more than expected).

Fields of papers citing papers by Ronald Feld

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald Feld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Feld. The network helps show where Ronald Feld may publish in the future.

Co-authorship network of co-authors of Ronald Feld

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald Feld. A scholar is included among the top collaborators of Ronald Feld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald Feld. Ronald Feld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evolution of Symptom Burden of Advanced Lung Cancer Over a Decade 2017 ·Clinical Lung Cancer ·Mike Sung, (unknown), (unknown), Lisa W. Le, Frances A. Shepherd, Ronald L. Burkes, Ronald Feld, Stephanie Lin, (unknown), Natasha B. Leighl	73
2	OA21.02 ALK-Rearranged Non-Small Cell Lung Cancer is Associated with a High Rate of Venous Thromboembolism 2017 ·Journal of Thoracic Oncology ·Alona Zer, Mor Moskovitz, David Hwang, Anat Hershko Klement, Ludmila Fridel, Grzegorz Korpanty, Elizabeth Dudnik, Nir Peled, Tzippy Shochat, Natasha B. Leighl, Geoffrey Liu, Ronald Feld, Ronald L. Burkes, Mira Wollner, Ming‐Sound Tsao, Frances A. Shepherd	1
3	Treatment options for patients with brain metastases from EGFR / ALK -driven lung cancer 2017 ·Radiotherapy and Oncology ·Mark Doherty, Grzegorz Korpanty, Pascale Tomasini, (unknown), Kevin Jao, Catherine Labbé, Céline Mascaux, Petra Martin, Suzanne Kamel‐Reid, Ming‐Sound Tsao, Melania Pintilie, Geoffrey Liu, Penelope A. Bradbury, Ronald Feld, Natasha B. Leighl, Caroline Chung, Frances A. Shepherd	40
4	Uncommon EGFR mutations in advanced non-small cell lung cancer 2017 ·Lung Cancer ·Grainne M. O’Kane, Penelope A. Bradbury, Ronald Feld, Natasha B. Leighl, Geoffrey Liu, (unknown), Suzanne Kamel‐Reid, Ming‐Sound Tsao, Frances A. Shepherd	103
5	Patients with Advanced Non–Small Cell Lung Cancer: Are Research Biopsies a Barrier to Participation in Clinical Trials? 2016 ·Journal of Thoracic Oncology ·(unknown), Mike Sung, Frances A. Shepherd, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ronald Feld, Geoffrey Liu, Natasha B. Leighl	47
6	Symptomatic Toxicities Experienced During Anticancer Treatment: Agreement Between Patient and Physician Reporting in Three Randomized Trials breakdown → 2015 ·Journal of Clinical Oncology ·Massimo Di Maïo, Ciro Gallo, Natasha B. Leighl, Maria Carmela Piccirillo, Gennaro Daniele, Francesco Nuzzo, Cesare Gridelli, Vittorio Gebbia, Fortunato Ciardiello, Sabino De Placido, Anna Ceribelli, Adolfo Favaretto, A. De Matteis, Ronald Feld, Charles Butts, Jane Bryce, Simona Signoriello, Alessandro Morabito, Gaetano Rocco, Francesco Perrone	330
7	Phase II Study of Concurrent Pemetrexed, Cisplatin, and Radiation Therapy for Stage IIIA/B Unresectable Non–Small Cell Lung Cancer 2015 ·Clinical Lung Cancer ·Anthony Brade, Robert M. MacRae, Scott A. Laurie, Andrea Bezjak, Ronald L. Burkes, Quincy S. Chu, John R. Goffin, John Cho, Andrew Hope, A. Sun, Natasha B. Leighl, (unknown), Ronald Feld, (unknown), Anwar Hossain, Neill Iscoe, Frances A. Shepherd	8
8	The impact of anemia on outcome of chemoradiation for limited small-cell lung cancer: a combined analysis of studies of the National Cancer Institute of Canada Clinical Trials Group 2007 ·Annals of Oncology ·Scott A. Laurie, Keyue Ding, (unknown), Ronald Feld, Nevin Murray, F. Shepherd, Lesley Seymour	10
9	The role of supportive care in quality of life 1996 ·Current Opinion in Oncology ·David Warr, Ronald Feld	2
10	Complications associated with the treatment of small cell lung cancer 1994 ·Lung Cancer ·Ronald Feld	1
11	Postoperative adjuvant therapy for non-small cell lung cancer: a consensus report 1994 ·Lung Cancer ·Daniel C. Ihde, David Ball, R. Arriagada, Nicole Barthélémy, Steven E. Benner, (unknown), G. Bureau, (unknown), Georges Deneffe, Bahman Emami, Ronald Feld, David Joseph, A. Paccagnella, P Rocmans, P. Van Houtte	8
12	The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer. 1991 ·Journal of Clinical Oncology ·Uri Sagman, Ronald Feld, William K. Evans, David Warr, F. Shepherd, David G. Payne, (unknown), J L Yeoh, George Deboer, A. Malkin	75
13	Surgical treatment for limited small-cell lung cancer 1991 ·Journal of Thoracic and Cardiovascular Surgery ·Frances A. Shepherd, Robert J. Ginsberg, Ronald Feld, William K. Evans, (unknown)	95
14	Late Complications Associated with the Treatment of Small-Cell Lung Cancer 1989 ·Cancer treatment and research ·Ronald Feld	1
15	A prospective study of adjuvant surgical resection after chemotherapy for limited small cell lung cancer 1989 ·Journal of Thoracic and Cardiovascular Surgery ·Frances A. Shepherd, Robert J. Ginsberg, G. Alexander Patterson, William K. Evans, Ronald Feld	100
16	Treatment of N2 Non-Small Cell Lung Cancer (NSCLC) 1989 ·CHEST Journal ·(unknown), Ronald Feld, (unknown), (unknown)	3
17	Prognostic factors for small cell carcinoma of the lung 1988 ·European Journal of Cancer and Clinical Oncology ·Ronald Feld, Gerrit DeBoer, Uri Sagman	10
18	Short course prophylactic cranial irradiation for small cell lung cancer 1985 ·American Journal of Clinical Oncology ·Ronald Feld, Gerald H. Clamon, Ronald H. Blum, Edgar M. Moran, Roy S. Weiner, Barnett S. Kramer, William K. Evans, (unknown), Freddie Ann Hoffman, Leon F. Burmeister	15
19	Effects of total parenteral nutrition and chemotherapy on the metabolic derangements in small cell lung cancer. 1984 ·PubMed ·(unknown), Moshe Shike, Errol B. Marliss, Allan S. Detsky, Frances A. Shepherd, Ronald Feld, William K. Evans, Khursheed N. Jeejeebhoy	68
20	Reduction in local recurrence and improved survival in surgically treated patients with small cell lung cancer 1983 ·Journal of Thoracic and Cardiovascular Surgery ·Frances A. Shepherd, Robert J. Ginsberg, William K. Evans, Ronald Feld, Joel D. Cooper, Riivo Ilves, Thomas R.J. Todd, F. Griffith Pearson, Paul F. Waters, Michael A. Baker, Gerrit DeBoer	70

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact